Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

Items Tagged ‘adalimumab’

August 29, 2014

Predicting Remission After Adalimumab Dose Optimization

By Margaret Shepard, Communications Specialist Margaret_Marie

Edward Loftus Jr., M. D., discusses a recent article published in the American Journal of Gastroenterology looking at patients on the standard dose of adalimumab, also known as Humira,  who were not doing well. The study focused on dose optimization and predicting remission in patients.   This French study looked at patients with either Crohn’s […]

View full entry

Tags: adalimumab, American Journal of Gastroenterology, Crohn's disease, Edward Loftus, ulcerative colitis


July 10, 2014

Cancer Risk Greater in Crohn’s Disease Patients Treated with Combination Drug Therapy

By Margaret Shepard, Communications Specialist Margaret_Marie

John Kisiel, M.D., discusses a recently published article in Gastroenterology about the combination therapy of adalimumab and immunomodulators and the risk for cancer in patients with Crohn’s disease.   Recent studies have shown greater benefit when combining anti-TNF drugs with thiopurine drugs. Doctors have known for awhile that certain thiopurine drugs raise the risk of certain […]

View full entry

Tags: adalimumab, AGA, cancer, Crohn's disease, Gastroenterology, John Kisiel, nonmelanoma skin cancer


February 19, 2014

Medications After Surgery Preventing the Reoccurrence of Crohn’s Disease

By Margaret Shepard, Communications Specialist Margaret_Marie

Ed Loftus, M. D., discusses a recent study published in The American Journal of Gastroenterology that examines if medications after surgery can effectively prevent reoccurrence of Crohn’s disease. Many patients find surgery to be beneficial in managing quality of life if they have obstructive symptoms, but many patients will have recurring symptoms. This study took place in Italy […]

View full entry

Tags: adalimumab, American Journal of Gastroenterology, Edward Loftus


Contact Us · Privacy Policy